A review of press coverage of our peer-reviewed studies and news items.
Press mentions continue for a 2015 study in The American Journal of Managed Care on the cost of waiting in the doctor’s office. The Heartland Institute cited the findings by Kristin N. Ray, MD, MS, and her co-authors in a feature about primary care physicians who were eager to learn about a payment model called direct primary care. Improving the patient experience in primary care is getting more attention; as Ray et al found, the average opportunity cost of $43 to visit the doctor exceeds the cost of most co-payments.
This week’s InFocus blog, “Getting Ready for Bundled Payments in Cardiac Care,” was featured on Healthcare Informatics. Editor-in-chief Mark Hagland appreciated insights from 2 healthcare consultants and the leader of cardiac care for New Jersey’s Lourdes Heath System, who observed that when looking for savings, it’s all about transitions of care. “First of all, discharge processes remain largely suboptimally managed at most hosptials today,” Hagland wrote. “To put it very bluntly, under ‘pure’ fee-for-service payment, the incentive is to let patients go and come back again.”
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More